ThingWorx’s Machine-to-Machine (M2M) platform and rapid application development tools enable the next generation of remote service and value-added services for Biocartis.
ThingWorx™ today announced that Biocartis, an innovative molecular diagnostics company, has selected ThingWorx as the Machine-to-Machine (M2M) application platform to power its next-generation remote service offering. Biocartis intends to use the ThingWorx application platform to provide remote instrument connectivity and innovative M2M applications, extending its molecular diagnostics solution with high-value remote service and value-added offerings for its customers and partners.
ThingWorx enables Biocartis to bring to market a next-generation remote service solution for its Molecular Diagnostics Platform, a unique DNA-based in vitro diagnostics system that it is currently developing for the emerging needs of personalized medicine. Biocartis is utilizing the rapid application development tools and M2M communications technology provided by the ThingWorx platform to develop the remote service solution. Using the extensibility and enterprise integration features that are core to the ThingWorx platform, Biocartis aims to deliver innovative, value-added services in addition to remote instrument monitoring.
“We are entering the ‘connected age’, an age that brings people, systems, and the ‘50 billion things’—sensors, devices, machines—together to provide the opportunity for a step change in operational innovation and resource efficiency,” said Rudi Pauwels, CEO of Biocartis.
“ThingWorx uniquely enables organizations to rapidly build and run connected applications to capture the business opportunities offered by the emerging pervasiveness of smart things.”
“We are pleased to be selected by Biocartis, an innovator in the molecular diagnostics industry,” said Russ Fadel, CEO of ThingWorx.
“The rapid time to market provided by ThingWorx, combined with the platform’s unique connectivity and business integration capabilities, enables our customers to create a competitive advantage in their markets. Biocartis’ selection of ThingWorx further validates our position as the leader in next-generation connected application development.”
